Physio-protective soothing body lotion

SENSINOL soothing milk is a daily treatment product indicated for patients with pruritus. From the first application, it soothes itching due to dry skin, calcareous water or cold. Thanks to its high tolerance formula, it is adapted for itching in senior subjects and also as an accompanying treatment for patients undergoing cancer treatment. 

  • For whom?
    Adults
    Pregnant woman
    Oncology
  • Price
    200ml
    16,90€
    400ml
    21,90€
  • Texture
    Fragrance free, alcohol free.

Patient relations

  • Application tips

    Apply as often as needed.

  • In combination with the following treatments

    During and after cancer treatment.
    (Itching on the bare scalp.)
Patient information sheets
To support your patients during their treatments
Prescriptions
To save time on your medical prescriptions in combination with dermo-cosmetic care routines

Ingredients

Active ingredients:

Polidocanol
Actif

Polidocanol (or Laureth-9) is a clear syrupy liquid. It is an active ingredient recognized for its antipruginous activity.

Prucidine-4®
Actif

Prucidin-4® (or pentylene glycol or 4-t-Butylcyclohexanol) is a synthetic active ingredient that comes in a clear liquid solution.

Glycerin
Actif

Active ingredient that nourishes and promotes the replenishment of the skin's protective hydrolipidic film.

Formula details:

WATER (AQUA)
GLYCERIN
CAPRYLIC/CAPRIC TRIGLYCERIDE
LAURETH-9
1,2-HEXANEDIOL
4-T-BUTYLCYCLOHEXANOL
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
CAPRYLYL GLYCOL
CARBOMER
GLYCERYL STEARATE
PEG-100 STEARATE
PENTYLENE GLYCOL
SODIUM HYDROXIDE
SORBITAN STEARATE
TROPOLONE

Click on an ingredient type to highlight it in the list

Water
Moisturizer
Nourisher
Active ingredient
Sensoriality and texture
Excipient

Clinical results and publications

Efficacy results

-99%

Of pruritus from the 1st application (2).

-92%

From xerosis to D28 (3).

24H

Hydration (4).

Tolerance results

Very good skin tolerance (1).

Legal Notice

Clinical study of tolerance and effectiveness in 55 adult subjects with dry to very dry skin and moderate to severe pruritus. 1 application per day for 4 weeks. 

(1) Tolerance rated by investigators. 

(2) Pruritus score (VAS, 0 to 10) rated by patients.

(3) Xerosis score (0 to 4) rated by investigators.

(4) 24-hour hydration kinetics after a single application in 14 adult subjects.

Illustrative macrophotographs of xerosis

Evolution after 1 month of use of Sensinol body lotion.

Macrophotographies illustratives de la xerose : J0

J0

Macrophotographies illustratives de la xerose : J28

J28

Discover the range

Filter by

All products
Hygiene
Care
Complementary care
DU_SENSINOL_Physio-protective-treatment-shampoo_Front_400ml_3282770138900
SENSINOL
Physio-protective treatment shampoo
View more
DU_SENSINOL_Soothing-physio-protective-serum_Front_30ml_3282779417006
SENSINOL
Soothing physio-protective serum
View more
DU_SENSINOL_Soothing-cleansing-oil_Front_400ml_3282770055061
SENSINOL
Soothing cleansing oil
View more

Contact us

Would you like to meet a sales representative?

Our medical sales representatives come to your workplace to answer all your questions about our brands and products.

Make an appointment

The product concerned may not be available in your country. Please contact your medical sales representative for further information.

Have you noticed any side effects?

The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!

Report an adverse reaction

Our commitments

Made in France

Product manufactured in our factories in France.

Conscious Care

Pierre Fabre Laboratories brands, including Ducray Dermatological Laboratories, have joined forces and collectively created Conscious Care: a dermo-cosmetic of the future that acts conscientiously towards its entire ecosystem.

Supporting associations

Ducray Dermatological Laboratories support 14 patient associations around the world, with the objective of sharing information on pathologies to improve their management.